Quantum BioPharma understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma Moves to Lead Class Action Over Alleged Stock Manipulation by Canadian Banks
- Quantum BioPharma Closes Private Placement, Enhances Governance
- Quantum BioPharma Ends Market Offering Agreement
- Quantum BioPharma’s Lawsuit Highlighted in CTV’s W5 Series
- Quantum BioPharma announces airing of news segment on manipulation lawsuit